TCTR20240423003招募中不适用
Assessment of Safety and efficacy of continuous intravenous Labetalol infusion for blood pressure control in patients with spontaneous intracerebral hemorrhage
Faculty of Medicine, Thammasat University0 个研究点目标入组 100 人开始时间: 2024年4月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1. Spontaneous ICH
- •2.Age more than 18 years
- •3. No secondary causes: AVM, aneurysm
排除标准
- •1.Secondary causes of ICH: AVM, aneurysm
- •2.Pregnancy
- •3.Traumatic intracerebral hemorrhage
研究者
相似试验
已完成
不适用
Evaluation of the safety and efficacy of continuous use of skincare formulationsHealthyJPRN-UMIN000039938Beauty & Health Research Inc.45
尚未招募
不适用
To evaluate the efficacy and safety of regional block of the abdomen( between 2 muscles) using ultrasound guidance after laparoscopic nephrectomy surgery - a clinical trialCTRI/2020/03/023760All India Institute of Medical Sciences Jodhpur
已完成
不适用
Evaluation of the safety and efficacy of continuous use of skincare formulationsHealthyJPRN-UMIN000039937Beauty & Health Research Inc.46
招募中
2 期
Assessment of efficacy and safety of continouation maintenance therapy with gemcitabine after cisplatin-gemcitabine induction chemotherapy in advanced squamous cell lung cancer (KTORG1302)squamous cell lung cancerJPRN-UMIN000010721Kyoto Thoracic Oncology Research Group (KTORG)60
尚未招募
3 期
A clinical trial to study the effects of two drugs, sustained release and immediate release mucoregulator in patients with bronchial asthma.CTRI/2010/091/000571Sun Pharmaceutical Industries Ltd.200